# A Clinical Study to Assess Preliminary Efficacy, Safety and Tolerability of HH-120 Nasal Spray in COVID-19 Patients

> **NCT05659602** · NA · COMPLETED · sponsor: **Beijing Ditan Hospital** · enrollment: 111 (actual)

## Conditions studied

- Coronavirus Disease 2019(COVID-19)

## Interventions

- **BIOLOGICAL:** HH-120 Nasal Spray

## Key facts

- **NCT ID:** NCT05659602
- **Lead sponsor:** Beijing Ditan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-09
- **Primary completion:** 2023-01-03
- **Final completion:** 2023-01-03
- **Target enrollment:** 111 (ACTUAL)
- **Last updated:** 2024-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05659602

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05659602, "A Clinical Study to Assess Preliminary Efficacy, Safety and Tolerability of HH-120 Nasal Spray in COVID-19 Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05659602. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*